company background image
000739 logo

Apeloa PharmaceuticalLtd SZSE:000739 Stock Report

Last Price

CN¥15.54

Market Cap

CN¥18.0b

7D

-11.4%

1Y

12.5%

Updated

11 Mar, 2025

Data

Company Financials +

Apeloa Pharmaceutical Co.,Ltd

SZSE:000739 Stock Report

Market Cap: CN¥18.0b

000739 Stock Overview

Provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally. More details

000739 fundamental analysis
Snowflake Score
Valuation6/6
Future Growth1/6
Past Performance2/6
Financial Health5/6
Dividends4/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

My Notes

Capture your thoughts, links and company narrative

Apeloa Pharmaceutical Co.,Ltd Competitors

Price History & Performance

Summary of share price highs, lows and changes for Apeloa PharmaceuticalLtd
Historical stock prices
Current Share PriceCN¥15.54
52 Week HighCN¥18.96
52 Week LowCN¥12.23
Beta0.14
1 Month Change1.44%
3 Month Change-6.44%
1 Year Change12.53%
3 Year Change-53.83%
5 Year Change-7.22%
Change since IPO848.62%

Recent News & Updates

Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Low P/E No Reason For Excitement

Feb 11
Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Low P/E No Reason For Excitement

We Think Apeloa PharmaceuticalLtd (SZSE:000739) Can Stay On Top Of Its Debt

Jan 13
We Think Apeloa PharmaceuticalLtd (SZSE:000739) Can Stay On Top Of Its Debt

Recent updates

Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Low P/E No Reason For Excitement

Feb 11
Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Low P/E No Reason For Excitement

We Think Apeloa PharmaceuticalLtd (SZSE:000739) Can Stay On Top Of Its Debt

Jan 13
We Think Apeloa PharmaceuticalLtd (SZSE:000739) Can Stay On Top Of Its Debt

Apeloa Pharmaceutical Co.,Ltd (SZSE:000739) Looks Inexpensive But Perhaps Not Attractive Enough

Nov 09
Apeloa Pharmaceutical Co.,Ltd (SZSE:000739) Looks Inexpensive But Perhaps Not Attractive Enough

Apeloa PharmaceuticalLtd (SZSE:000739) Seems To Use Debt Quite Sensibly

Sep 30
Apeloa PharmaceuticalLtd (SZSE:000739) Seems To Use Debt Quite Sensibly

Lacklustre Performance Is Driving Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Low P/E

Aug 07
Lacklustre Performance Is Driving Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Low P/E

Is Apeloa PharmaceuticalLtd (SZSE:000739) Using Too Much Debt?

Jun 24
Is Apeloa PharmaceuticalLtd (SZSE:000739) Using Too Much Debt?

Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

May 08
Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Shareholder Returns

000739CN PharmaceuticalsCN Market
7D-11.4%0.9%2.3%
1Y12.5%0.7%12.7%

Return vs Industry: 000739 exceeded the CN Pharmaceuticals industry which returned 0.7% over the past year.

Return vs Market: 000739 matched the CN Market which returned 12.7% over the past year.

Price Volatility

Is 000739's price volatile compared to industry and market?
000739 volatility
000739 Average Weekly Movement4.9%
Pharmaceuticals Industry Average Movement4.7%
Market Average Movement6.2%
10% most volatile stocks in CN Market10.4%
10% least volatile stocks in CN Market3.5%

Stable Share Price: 000739 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 000739's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19897,208Chun Hewww.apeloa.com

Apeloa Pharmaceutical Co.,Ltd provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally. The company offers preparation products, including cardio-cerebrovascular, anti-infection, anti-tumor, anti-viral, and special drugs. It offers its products under the Tianliwei, Beshin, Yosemade, Jutai, and other brands.

Apeloa Pharmaceutical Co.,Ltd Fundamentals Summary

How do Apeloa PharmaceuticalLtd's earnings and revenue compare to its market cap?
000739 fundamental statistics
Market capCN¥18.00b
Earnings (TTM)CN¥1.03b
Revenue (TTM)CN¥12.02b

17.5x

P/E Ratio

1.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
000739 income statement (TTM)
RevenueCN¥12.02b
Cost of RevenueCN¥9.16b
Gross ProfitCN¥2.87b
Other ExpensesCN¥1.84b
EarningsCN¥1.03b

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.89
Gross Margin23.85%
Net Profit Margin8.58%
Debt/Equity Ratio13.8%

How did 000739 perform over the long term?

See historical performance and comparison

Dividends

2.0%

Current Dividend Yield

34%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/11 17:19
End of Day Share Price 2025/03/11 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Apeloa Pharmaceutical Co.,Ltd is covered by 9 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Wanhua WuChina International Capital Corporation Limited
Kai WangCitic Securities Co., Ltd.
Siyu PengGuosen Securities Co., Ltd.